Sunitinib treatment modification in metastatic renal cell carcinoma – the impact of 2/1 dosing schedule and dose reduction in survival outcomes

Valente A.D.C.,J. Costa M.,Nogueira Costa I.,Reis J., Baptista Freitas M., Lopes Almeida C., Teixeira C., Veloso Gonçalves M., Ribeiro M.J., Meireles S., Barbosa M., Augusto I.

European Urology Open Science（2022）

引用 0|浏览2